Revolutionizing Peptide Therapies

On Target Therapeutics (oTTx) is a Massachusetts based biotech company utilizing technology originally developed in the laboratory of Dr. Alan Kopin at Tufts Medical Center in Boston.  OTTx is focused on developing stable long acting peptide modulators of GPCRs for a variety of diseases.